Athanor Capital, LP Cytokinetics Inc Transaction History

Athanor Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $197,622 - $269,522	-9,986 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$18.57 - $25.68 $290,861 - $402,225	-15,663 Reduced 61.07%	9,986 $232,000
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $391,403 - $733,817	25,649 New	25,649 $533,000
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $858,103 - $1.21 Million	-41,696 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$11.15 - $24.64 $464,910 - $1.03 Million	41,696 New	41,696 $983,000
Q1 2020 May 14, 2020	SELL	$8.75 - $16.3 $398,903 - $743,100	-45,589 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $126,492 - $188,386	-15,911 Reduced 25.87%	45,589 $484,000
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $432,800 - $570,000	40,000 Added 186.05%	61,500 $700,000
Q2 2019 Aug 13, 2019	BUY	$7.95 - $11.25 $170,925 - $241,875	21,500 New	21,500 $242,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.